SARS-COV-2 (IGG) NUCLEOCAPSID(O)

Message
***To meet regulatory reporting requirements for COVID-19 testing, the patient's address, phone number and other demographic details are required for this order.***


Test Code
SARS-COV-2 (IGG) NUCLEOCAPSID(O)


CPT Codes
86769

Preferred Specimen
1 mL serum


Minimum Volume
0.5 mL


Other Acceptable Specimens
Frozen serum in a plastic transport vial


Instructions
Do not freeze whole blood or any samples stored in a primary tube


Transport Container
Transport tube


Transport Temperature
Refrigerated


Specimen Stability
Room temperature: 4 days
Refrigerated: 7 days
Frozen: 30 days


Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Gross hemolysis • Grossly lipemic • Grossly icteric • Frozen Serum Separator Tube (SST®)


Methodology
Immunoassay (IA)

Setup Schedule
Daily


Report Available
Next day


Reference Range
Negative


Clinical Significance
SARS-CoV-2 Antibody (IgG), Nucleocapsid, Qualitative - This test is intended as an aid in identifying individuals with antibodies to SARS-CoV-2. A positive result indicates an immune response to a recent or prior infection with SARS-CoV-2. This test would not be expected to detect an immune response to a spike vaccine. It is unknown for how long antibodies persist following infection or if the presence of antibodies confers protective immunity. This assay should not be used to diagnose acute SARS-CoV-2 infection.


Performing Laboratory
Quest Diagnostics Nichols Institute

Additional Information
Click here

Last Updated: October 2, 2025


The CPT Codes provided in this document are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed. Any Profile/panel component may be ordered separately. Reflex tests are performed at an additional charge.